EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H27N3O2S |
| Net Charge | 0 |
| Average Mass | 433.577 |
| Monoisotopic Mass | 433.18240 |
| SMILES | O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2n1 |
| InChI | InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29) |
| InChIKey | ZKIAIYBUSXZPLP-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Applications: | antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| brexpiprazole (CHEBI:134716) has role antidepressant (CHEBI:35469) |
| brexpiprazole (CHEBI:134716) has role antipsychotic agent (CHEBI:35476) |
| brexpiprazole (CHEBI:134716) is a N-arylpiperazine (CHEBI:46848) |
| INN | Source |
|---|---|
| brexpiprazol | WHO MedNet |
| Synonyms | Source |
|---|---|
| Brexpiprazole | ChEMBL |
| OPC 34712 | DrugCentral |
| OPC-34712 | DrugCentral |
| rexulti | DrugCentral |
| Brand Name | Source |
|---|---|
| Rxulti | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 5014 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:913611-97-9 | DrugCentral |
| Citations |
|---|